RNA, U6 small nuclear 591, pseudogene (RNU6-591P)

RNU6-591P is classified as a pseudogene, originating from the U6 small nuclear RNA (snRNA) gene, a family involved in mRNA splicing in the nucleus of eukaryotic cells[3][7]. Unlike functional U6 snRNA, which contributes directly to the catalytic core of the spliceosome, a pseudogene like RNU6-591P is not transcribed into a functional product and does not participate in spliceosomal assembly or RNA splicing[4][7]. The presence of multiple U6 pseudogenes in the human genome reflects the evolutionary history and functional importance of genuine U6 snRNA, but pseudogenes themselves generally lack biological activity or therapeutic relevance[3][7]. No evidence from current genetic databases or literature suggests RNU6-591P is a molecular target, nor is it associated with drug interactions, disease roles, or established as a biomarker[4]. The abbreviation "RNU6-591P" is standardized in genomic nomenclature for this locus. Key Points: - Pseudogene, not a protein-coding gene or active RNA: RNU6-591P does not produce functional RNA or protein[4][7]. - No therapeutic relevance: It is not considered a target for drugs or therapies. - No known biological function or disease role: As with most pseudogenes, there is no evidence for regulatory function or pathological involvement[4][7]. - Correct nomenclature but non-critical entity: Name and abbreviation properly reflect its genomic status. If you need information about the functional U6 snRNA molecule or snRNP, refer to canonical U6 snRNA entries; pseudogenes such as RNU6-591P are generally excluded from therapeutic target reference sources[3][4][7].

Other names

RNU6-591P